The knock on the company is going stale: this quarter's own facts cut against the standing doubt
The model's full reasoning — Q2 2022 call → NO我们根据要求分析。需要判断是否存在一个明确的、公司特定的疑虑,并且本季度的实际运营证据是否反驳了该疑虑。 从电话会议中,我们看到分析师提问涉及:存款流失、费用增长、贷款增长、PCSB合并、利率风险等。但最突出的、反复出现的疑虑是什么? 阅读全文,管理层多次提到“people buying our customers”(客户被收购),导致贷款增长低于预期。Paul说“I can't wait for people to stop buying our customers.” 这似乎是一个持续的问题:客户被收购导致贷款流失。但这是否是“standing doubt”?分析师没有直接问这个问题,但管理层自己提到了。另外,关于PCSB合并,分析师问更新,管理层说一切按计划进行。但这不是疑虑。 另一个可能:关于Clarendon Private(私人银行)的盈利问题。分析师问“any updates on Clarendon private, what assets are up to or are we getting close to breakeven?” 管理层回答“We do expect this to breakeven in three years that would be 2.5 years. They're right on track with where we expected.” 这似乎是一个疑虑:该业务何时盈利?管理层说按计划进行。但这是否是“standing doubt”?分析师明确问了,说明存在疑虑。但本季度的证据是什么?管理层说“right on track”,但并没有给出具体数字,只是说“doing excellent”。这更多是信心而非实际证据。 另一个:关于存款下降。分析师问存款增长,管理层解释是季节性、税收等,并说“Already to-date we're halfway back to that reduction” 即已经恢复了一半。这可能是实际证据。 但我们需要找到一个明确的、公司特定的疑虑,并且本季度有实际运营证据反驳。最明显的可能是:贷款增长因客户被收购而受阻,但本季度仍有增长?或者关于PCSB合并的完成时间?但那是预期。 再读一遍:分析师Mark问“any updates on Clarendon private, what assets are up to or are we getting close to breakeven?” 这明确是一个疑虑:该业务何时盈利?管理层回答“They're right on track with where we expected.” 但并没有提供具体数字,只是说“doing excellent”。这更像是信心而非实际证据。而且“breakeven in three years”是计划,不是本季度发生的。 另一个疑虑可能是关于存款流失,但那是季节性的。 或许疑虑是关于“客户被收购”导致贷款增长乏力?但管理层说“we are making some gain nonetheless” 并且“originations were strong”。但这是否是standing doubt?分析师没有直接问,但管理层自己提到“I can't wait for people to stop buying our customers.” 这暗示这是一个持续的问题。但本季度的证据是:核心贷款增长$82 million,虽然低于预期,但仍是正增长。这算反驳吗?可能。 但更明确的是:关于PCSB合并,分析师问“any update as to the timing of the PCSB merger close?” 管理层说“everything is on target for Q4.” 这没有疑虑。 我认为最符合的是关于Clarendon Private的盈利问题。但管理层没有提供本季度的实际数据,只是说“on track”。这不符合“本季度实际活动反驳”的要求。 另一个可能:关于费用增长,但那是普遍问题。 再考虑:是否有疑虑关于“legacy business's decline”之类?没有。 或许疑虑是关于“deposit beta”或“margin”但那是预测。 仔细看,分析师Laurie问“can you give us a refresh now on where we are with interest rates? I know you had at announcement and it seems like ages ago, you had a $19 million interest rate mark on loans...” 这是关于PCSB合并的会计影响,但那是预期。 我认为没有明确的、公司特定的、长期存在的疑虑被本季度实际证据反驳。管理层回答了很多问题,但大多是信心和计划。 因此,答案应为NO。 但让我们再确认:是否有分析师反复问同一个问题?没有。只有一次问Clarendon。 所以,我认为没有符合的。答案NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| IFS | Intercorp Financial Services Inc. | Q1 2024 | 2024-05-14 | C+ |
| PRA | ProAssurance Corporation | Q1 2024 | 2024-05-11 | D |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| GL | Globe Life Inc. | Q1 2024 | 2024-04-23 | F |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| ALL | The Allstate Corporation | Q3 2023 | 2023-11-02 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| PTN | Palatin Technologies, Inc. | Q4 2023 | 2023-09-29 | D |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| BXSL | Blackstone Secured Lending Fund | Q1 2023 | 2023-05-10 | A |
| FTHM | Fathom Holdings, Inc. | Q1 2023 | 2023-05-10 | C |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| SBRA | Sabra Health Care REIT, Inc. | Q1 2023 | 2023-05-04 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| CLSD | Clearside Biomedical, Inc. | Q3 2022 | 2022-11-09 | C |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| EXFY | Expensify, Inc. | Q2 2022 | 2022-08-12 | D |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| XHR | Xenia Hotels & Resorts, Inc. | Q2 2022 | 2022-08-05 | A |
| LIN | Linde plc | Q2 2022 | 2022-07-28 | B+ |
| CME | CME Group Inc. | Q2 2022 | 2022-07-27 | B |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| SE | Sea Limited | Q1 2022 | 2022-05-17 | F |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FARM | Farmer Bros. Co. | Q3 2022 | 2022-05-07 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| SXC | SunCoke Energy, Inc. | Q3 2021 | 2021-11-01 | A |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| EEX | Emerald Holding, Inc. | Q2 2021 | 2021-08-01 | C+ |
| GECC | Great Elm Capital Corporation | Q3 2018 | 2018-11-13 | B |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| BCOV | Brightcove Inc. | Q1 2018 | 2018-04-26 | B+ |
| AVT | Avnet, Inc. | Q2 2018 | 2018-01-25 | B |
| PII | Polaris Inc. | Q3 2017 | 2017-10-24 | C+ |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| MTG | MGIC Investment Corporation | Q3 2017 | 2017-10-18 | B+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| CAG | Conagra Brands, Inc. | Q2 2017 | 2016-12-22 | C+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| ULBI | Ultralife Corporation | Q3 2016 | 2016-10-29 | C+ |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| GES | Guess?, Inc. | Q1 2017 | 2016-05-25 | F |
| RCL | Royal Caribbean Cruises Ltd. | Q1 2016 | 2016-04-29 | C+ |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
BRX · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible on the call, and if this period's operating evidence cuts against it. YES The standing doubt is the skepticism that tenant disruptions (especially bankruptcies like Bed Bath) will create occupancy pressure and throw markets out of equilibrium, given the recaptured space and potential for more filings. This is visible in analyst questions (Todd Thomas on Bed Bath impact and market equilibrium; others circling back on bad debt 75-110 bps and bankruptcy activity) and management's acknowledgment that "recent retailer bankruptcy announcements will result in occupancy pressure" while noting they've "been preparing for the last several quarters." This period's evidence cuts against it: record 94% total occupancy (up sequentially in a seasonally weak quarter), small-shop at 89.
CME · Q2 2022 → YESThe question is: Identify ONE well-defined DOUBT that has been weighing on the company, and see if the current period's operating evidence moves against that doubt. YES The standing doubt is the perceived risk that the legacy NEX Group businesses (BrokerTec and EBS) would continue to show range-bound revenue and fail to deliver meaningful growth despite a constructive macro backdrop, as directly raised by Alex Blostein. Management engages this concern head-on by recounting concrete operating evidence from 2Q: BrokerTec US treasuries ADV up 14% YoY, US repo up 25% YoY, EU repo up 14% YoY, plus $4.5 billion in new cross-sell volume from previously non-trading clients and record RV trading volumes of $2.4 billion; 90% of the migration to Globex is complete, with the remaining EBS migration also finished and system enhancements underway.
BXSL · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible in the transcript, and if this period's operating evidence moves against it. YES The standing doubt visible in the transcript is the skepticism that BXSL’s credit performance will be materially worse than the broader private-credit market because of its exposure to higher-rate environments and the “tails” of the portfolio (i.e., the small slice of companies whose interest-coverage ratios could fall below 1× when 5 % rates are stress-tested). Management itself flags this concern by noting that “it is less about averages… much more about the tails” and that investors keep asking about the percentage of the portfolio below 1× ICR. This quarter’s operating evidence directly counters that doubt: - 0.